Figure 1.
Figure 1. Freedom from progression for stage I/II patients achieving CR versus less than CR after two cycles ABVD in NCIC/EORTC Trial. Modified from Meyer et al.17

Freedom from progression for stage I/II patients achieving CR versus less than CR after two cycles ABVD in NCIC/EORTC Trial. Modified from Meyer et al.17 

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal